Marie A Labouesse1, Erik R Gertz2, Brian D Piccolo3, Elaine C Souza3, Gertrud U Schuster3, Megan G Witbracht3, Leslie R Woodhouse4, Sean H Adams5, Nancy L Keim5, Marta D Van Loan6. 1. AgroParisTech, Paris Institute of Science and Technology, for Life, Food and Environmental Sciences, Paris, France. 2. Obesity & Metabolism Research Unit, USDA, ARS, Western Human Nutrition Research Center, 430 West Health Sciences Drive, Davis, CA, USA. 3. Department of Nutrition, University of California, Davis, 1 Shields Avenue, Davis, CA, USA. 4. Analytical Support Laboratory, USDA, ARS, Western Human Nutrition Research Center, 430 West Health Sciences Drive, Davis, CA, USA. 5. Obesity & Metabolism Research Unit, USDA, ARS, Western Human Nutrition Research Center, 430 West Health Sciences Drive, Davis, CA, USA; Department of Nutrition, University of California, Davis, 1 Shields Avenue, Davis, CA, USA. 6. Obesity & Metabolism Research Unit, USDA, ARS, Western Human Nutrition Research Center, 430 West Health Sciences Drive, Davis, CA, USA; Department of Nutrition, University of California, Davis, 1 Shields Avenue, Davis, CA, USA. Electronic address: marta.vanloan@ars.usda.gov.
Abstract
INTRODUCTION: Weight loss reduces co-morbidities of obesity, but decreases bone mass. PURPOSE: Our aims were to (1) determine if adequate dairy intake attenuates weight loss-induced bone loss; (2) evaluate the associations of endocrine, inflammatory and bone markers, anthropometric and other parameters to bone mineral density and content (BMD, BMC) pre- and post-weight loss; and (3) model the contribution of these variables to post weight-loss BMD and BMC. METHODS: Overweight/obese women (BMI: 28-37 kg/m2) were enrolled in an energy reduced (-500 kcal/d; -2092 kJ/d) diet with adequate dairy (AD: 3-4 servings/d; n=25, 32.2±8.8 years) or low dairy (LD: ≤1 serving/d; n=26, 31.7±8.4 years). BMD, BMC and body composition were measured by DXA. Bone markers (CTX, PYD, BAP, OC), endocrine (PTH, vitamin D, leptin, adiponectin, ghrelin, amylin, insulin, GLP-1, PAI-1, HOMA) and inflammatory markers (CRP, IL1-β, IL-6, IL-8, TNF-α, cortisol) were measured in serum or plasma. PA was assessed by accelerometry. RESULTS: Following weight loss, AD intake resulted in significantly greater (p=0.004) lumbar spine BMD and serum osteocalcin (p=0.004) concentration compared to LD. Pre- and post-body fat was negatively associated with hip and lumbar spine BMC (r=-0.28, p=0.04 to -0.45, p=0.001). Of note were the significant negative associations among bone markers and IL-1β, TNFα and CRP ranging from r = -0.29 (p=0.04) to r = -0.34 (p=0.01); magnitude of associations did not change with weight loss. Adiponectin was negatively related to change in osteocalcin. Factor analysis resulted in 8 pre- and post-weight loss factors. Pre-weight loss factors accounted for 13.7% of the total variance in pre-weight loss hip BMD; post-weight loss factors explained 19.6% of the total variance in post-weight loss hip BMD. None of the factors contributed to the variance in lumbar spine BMD. CONCLUSION: AD during weight loss resulted in higher lumbar spine BMD and osteocalcin compared to LD. Significant negative associations were observed between bone and inflammatory markers suggesting that inflammation suppresses bone metabolism. Using factor analysis, 19.6% of total variance in post-weight loss hip BMD could be explained by endocrine, immune, and anthropometric variables, but not lumbar spine BMD. Published by Elsevier Inc.
INTRODUCTION:Weight loss reduces co-morbidities of obesity, but decreases bone mass. PURPOSE: Our aims were to (1) determine if adequate dairy intake attenuates weight loss-induced bone loss; (2) evaluate the associations of endocrine, inflammatory and bone markers, anthropometric and other parameters to bone mineral density and content (BMD, BMC) pre- and post-weight loss; and (3) model the contribution of these variables to postweight-loss BMD and BMC. METHODS: Overweight/obesewomen (BMI: 28-37 kg/m2) were enrolled in an energy reduced (-500 kcal/d; -2092 kJ/d) diet with adequate dairy (AD: 3-4 servings/d; n=25, 32.2±8.8 years) or low dairy (LD: ≤1 serving/d; n=26, 31.7±8.4 years). BMD, BMC and body composition were measured by DXA. Bone markers (CTX, PYD, BAP, OC), endocrine (PTH, vitamin D, leptin, adiponectin, ghrelin, amylin, insulin, GLP-1, PAI-1, HOMA) and inflammatory markers (CRP, IL1-β, IL-6, IL-8, TNF-α, cortisol) were measured in serum or plasma. PA was assessed by accelerometry. RESULTS: Following weight loss, AD intake resulted in significantly greater (p=0.004) lumbar spine BMD and serum osteocalcin (p=0.004) concentration compared to LD. Pre- and post-body fat was negatively associated with hip and lumbar spine BMC (r=-0.28, p=0.04 to -0.45, p=0.001). Of note were the significant negative associations among bone markers and IL-1β, TNFα and CRP ranging from r = -0.29 (p=0.04) to r = -0.34 (p=0.01); magnitude of associations did not change with weight loss. Adiponectin was negatively related to change in osteocalcin. Factor analysis resulted in 8 pre- and post-weight loss factors. Pre-weight loss factors accounted for 13.7% of the total variance in pre-weight loss hip BMD; post-weight loss factors explained 19.6% of the total variance in post-weight loss hip BMD. None of the factors contributed to the variance in lumbar spine BMD. CONCLUSION: AD during weight loss resulted in higher lumbar spine BMD and osteocalcin compared to LD. Significant negative associations were observed between bone and inflammatory markers suggesting that inflammation suppresses bone metabolism. Using factor analysis, 19.6% of total variance in post-weight loss hip BMD could be explained by endocrine, immune, and anthropometric variables, but not lumbar spine BMD. Published by Elsevier Inc.
Entities:
Keywords:
Body composition; Endocrine and inflammatory markers; Physical activity; Weight loss induced bone loss
Authors: Mariana Cifuentes; Claudia S Riedt; Robert E Brolin; M Paul Field; Robert M Sherrell; Sue A Shapses Journal: Am J Clin Nutr Date: 2004-07 Impact factor: 7.045
Authors: Matthew P Thorpe; Edward H Jacobson; Donald K Layman; Xuming He; Penny M Kris-Etherton; Ellen M Evans Journal: J Nutr Date: 2008-06 Impact factor: 4.798
Authors: Marta D Van Loan; Nancy L Keim; Sean H Adams; Elaine Souza; Leslie R Woodhouse; Anthony Thomas; Megan Witbracht; Erik R Gertz; Brian Piccolo; Andrew A Bremer; Michael Spurlock Journal: J Obes Date: 2011-09-14
Authors: Jeffrey B Driban; Charles B Eaton; Grace H Lo; Lori Lyn Price; Bing Lu; Mary F Barbe; Timothy E McAlindon Journal: Clin Rheumatol Date: 2015-12-21 Impact factor: 2.980
Authors: Brian D Piccolo; Nancy L Keim; Oliver Fiehn; Sean H Adams; Marta D Van Loan; John W Newman Journal: J Nutr Date: 2015-01-28 Impact factor: 4.798
Authors: Sifat Maria; Rebekah M Samsonraj; Fahima Munmun; Jessica Glas; Maria Silvestros; Mary P Kotlarczyk; Ryan Rylands; Amel Dudakovic; Andre J van Wijnen; Larry T Enderby; Holly Lassila; Bala Dodda; Vicki L Davis; Judy Balk; Matt Burow; Bruce A Bunnell; Paula A Witt-Enderby Journal: J Pineal Res Date: 2018-01-17 Impact factor: 13.007
Authors: N R Fuggle; L D Westbury; H E Syddall; N A Duggal; S C Shaw; K Maslin; E M Dennison; J Lord; C Cooper Journal: Osteoporos Int Date: 2018-07 Impact factor: 4.507
Authors: Daniel Courteix; João Valente-dos-Santos; Béatrice Ferry; Gérard Lac; Bruno Lesourd; Robert Chapier; Geraldine Naughton; Geoffroy Marceau; Manuel João Coelho-e-Silva; Agnès Vinet; Guillaume Walther; Philippe Obert; Frédéric Dutheil Journal: PLoS One Date: 2015-09-16 Impact factor: 3.240
Authors: Andrea Palermo; Dario Tuccinardi; Giuseppe Defeudis; Mikiko Watanabe; Luca D'Onofrio; Angelo Lauria Pantano; Nicola Napoli; Paolo Pozzilli; Silvia Manfrini Journal: Int J Environ Res Public Health Date: 2016-05-28 Impact factor: 3.390
Authors: Judit Tenk; Péter Mátrai; Péter Hegyi; Ildikó Rostás; András Garami; Imre Szabó; Margit Solymár; Erika Pétervári; József Czimmer; Katalin Márta; Alexandra Mikó; Nóra Füredi; Andrea Párniczky; Csaba Zsiborás; Márta Balaskó Journal: PLoS One Date: 2016-11-21 Impact factor: 3.240